ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1205

OARSI Initiative to Develop Classification Criteria for Early-Stage Symptomatic Knee OA (EsSKOA): What Should Be Considered in the Differential Diagnosis of EsSKOA?

Gillian Hawker1, Lauren King1, Jean Liew2, Quike Wang3, Armaghan Mahmoudian4, Nuria Jansen5, Ian Stanaitis6, Jos Runhaar5, Tom Appleton7, Aleksandra Turkiewicz8, Martin Englund9, Stefan Lohmander9, Ida Kristin Haugen10 and Tuhina Neogi11, and OARSI Early-stage Symptomatic Knee Osteoarthritis Initiative, 1University of Toronto, Toronto, ON, Canada, 2Boston University, Boston, MA, 3Shanghai Sixth People's Hospital, Shanghai, China (People's Republic), 4University of West Florida, Pensacola, FL, 5Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands, 6Women's College Hospital, Toronto, ON, Canada, 7The University of Western Ontario, London, ON, Canada, 8,Lund University, Lund, Sweden, 9Lund University, Lund, Sweden, 10Diakonhjemmet Hospital, Oslo, Norway, 11Boston University Chobanian & Avedisian School of Medicine, Boston, MA

Meeting: ACR Convergence 2024

Keywords: classification criteria, Diagnostic criteria, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoarthritis Research Society International (OARSI) has launched an initiative to develop classification criteria for early-stage symptomatic knee osteoarthritis (EsSKOA). In individuals with undiagnosed knee symptoms, the criteria aim to identify those with knee OA without established radiographic OA for entry into OA prevention trials. An international Delphi survey generated candidate items to be considered in the criteria. The next step is to assess the capacity of these items to increase or decrease the likelihood of EsSKOA versus other conditions (mimics). The current study sought to elicit diverse clinicians’ differential diagnosis for people presenting with undiagnosed knee symptoms.

Methods: An online survey was sent to clinicians who consult on individuals with knee symptoms (e.g., physiotherapy, sports medicine, physiatry, and others). Participants were recruited from Delphi survey respondents, purposive sampling of initiative member’s networks, and snowball sampling (participants invited other individuals to participate). Those who see, on average, at least five patients per month with undiagnosed knee symptoms were eligible. Three cases scenarios were presented: 50 yrs. with 8-months of knee discomfort while walking; 60 yrs. with intense knee discomfort getting out of a car 1 week ago; and 40 yrs. with 1 month of knee stiffness and swelling. For each, participants were asked if they see such people in their practice (yes/no). If yes, they were asked to indicate the top three differential diagnoses from a predefined list of conditions, and any other conditions we may have missed (open text box). Demographic and practice characteristics were collected to describe participants.

Results: 127 clinicians responded (43% female, 48% in practice ≤ 15 years, 50% academics). Table 1 Participants represented 8 clinical disciplines (32% sports medicine; 21% rheumatology; 14% general practice; 13% physiotherapy; 13% orthopaedics; and 6% physiatry) and 6 continents (59% North America; 24% Europe, 8% Asia, 6% Australia, 2% Africa; and 1% South America). Knee OA, including patellofemoral OA, was among the top three conditions in the differential diagnosis for all three scenarios, followed by patellofemoral pain syndrome (scenario 1), meniscal injuries (scenarios 1 and 2), collateral and cruciate ligament injuries (scenario 2), and conditions associated with knee swelling, e.g., bursitis and inflammatory arthritis (scenario 3) Table 2. Other conditions were identified (referred pain from the hip or lumbar spine, avascular necrosis of the knee, fracture, plica syndrome, and hemarthrosis), but none was considered among the top three conditions for any scenario.

Conclusion: From our survey of a large, diverse group of musculoskeletal clinicians, the differential diagnosis of people presenting with undiagnosed knee symptoms should include knee OA, meniscal, ligament and tendon injuries, bursitis, and inflammatory arthritis. Data collected on patients with these conditions will be required to assess the ability of our candidate items, alone and in combination, to discriminate individuals with EsSKOA from individuals with other common conditions.

Supporting image 1

Supporting image 2


Disclosures: G. Hawker: None; L. King: None; J. Liew: None; Q. Wang: None; A. Mahmoudian: None; N. Jansen: None; I. Stanaitis: None; J. Runhaar: None; T. Appleton: AbbVie/Abbott, 2, 5, 6, Novartis, 2, 5, 6, Pfizer, 2, 6, Servier, 5; A. Turkiewicz: None; M. Englund: Cellcolabs AB, 2, Grünenthal Sweden AB, 2, Key2Compliance AB, 2; S. Lohmander: Arthro Therapeutics, 2, Rho inc., 1; I. Haugen: AbbVie/Abbott, 2, GlaxoSmithKlein(GSK), 2, Grünenthal, 2, Novartis, 2, Pfizer/Lily, 5; T. Neogi: Amgen, 2, Eli Lilly, 2, GlaxoSmithKlein(GSK), 2, Novartis, 2, Sobi, 2.

To cite this abstract in AMA style:

Hawker G, King L, Liew J, Wang Q, Mahmoudian A, Jansen N, Stanaitis I, Runhaar J, Appleton T, Turkiewicz A, Englund M, Lohmander S, Haugen I, Neogi T. OARSI Initiative to Develop Classification Criteria for Early-Stage Symptomatic Knee OA (EsSKOA): What Should Be Considered in the Differential Diagnosis of EsSKOA? [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/oarsi-initiative-to-develop-classification-criteria-for-early-stage-symptomatic-knee-oa-esskoa-what-should-be-considered-in-the-differential-diagnosis-of-esskoa/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/oarsi-initiative-to-develop-classification-criteria-for-early-stage-symptomatic-knee-oa-esskoa-what-should-be-considered-in-the-differential-diagnosis-of-esskoa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology